v3.26.1
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (11,873,612) $ (4,957,165)
Adjustments for:    
Depreciation and amortization 76,976 93,405
Share-based compensation 1,432,178 325,217
Changes in working capital items:    
Accounts and other receivable 412,592 (18,159)
Prepaid expenses and other current assets (145,111) 73,355
Accounts payable and accrued liabilities 2,910,348 (1,117,921)
Net cash used in operating activities (7,186,629) (5,601,268)
Cash flows from financing activities:    
Proceeds from issuance of common shares 6,997,816 7,497,133
Proceeds from issuance of Series A-1 preferred shares and warrants 0 1,540,820
Payment for issuance costs of warrants 0 (23,446)
Net cash provided by financing activities 6,793,376 16,844,415
Effect of exchange rate changes on cash and cash equivalents    
Effect of exchange rate changes on cash and cash equivalents (66,399) 81,223
Net change in cash and cash equivalents (459,652) 11,324,370
Cash and cash equivalents, beginning of the period 10,792,172 1,037,320
Cash and cash equivalents, end of the period 10,332,520 12,361,690
Series B-1 Preferred Stock [Member]    
Cash flows from financing activities:    
Proceeds from issuance of Series B-1 preferred shares 0 8,340,000
Common Stock and Warrants [Member]    
Cash flows from financing activities:    
Payments for issuance costs of common shares (204,440) (294,935)
Preferred Stock [Member]    
Cash flows from financing activities:    
Payments for issuance costs of common shares $ 0 $ (215,157)